Top

International Journal of Colorectal Disease

Published in:

01-03-2004 | Original Article

Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression

Authors: S. Lassmann, M. Bauer, R. Rosenberg, H. Nekarda, R. Soong, R. Rüger, H. Höfler, M. Werner

Published in: International Journal of Colorectal Disease | Issue 2/2004

Abstract

Background and aims

Evaluation of cytokeratin 20 (CK20) specific quantitative reverse transcriptase polymerase chain reaction (QRT-PCR) and immunohistochemistry (IHC) for detection of occult tumor cells in lymph nodes of 72 patients with colorectal carcinoma (UICC stage I and II).

Methods

Serial sections of formalin-fixed, paraffin-embedded lymph nodes (mean 14.3/case) were used for microdissection, RNA isolation and QRT-PCR and for CK20 IHC using routine protocols. Results of QRT-PCR and IHC were compared and correlated to the CK20 expression pattern of the primary tumors and clinical follow-up.

Results

IHC revealed CK20-positive tumor cells in lymph nodes of 14.5% (10/69) and 0% (0/3) cases with a CK20-positive and CK20-negative primary tumor, respectively. CK20 mRNA was detected in the lymph nodes of 36.8% (7/19) cases by QRT-PCR with all 7 cases also expressing CK20 mRNA in the primary tumor. CK20 mRNA (QRT-PCR) and protein (IHC) detection in serial sections did not agree in 25% (5/20) of cases. A trend was seen towards a worse disease course for patients with CK20-positive lymph nodes by IHC (incidence of recurrent disease) and QRT-PCR (disease-free survival, incidence of recurrent disease).

Conclusion

CK20-specific IHC and QRT-PCR are supportive tools to conventional histology for detection of occult tumor cells in archival tissues, with the restriction that a laborious QRT-PCR procedure is necessary to achieve appropriate specificity. A prognostic value of CK20 IHC or QRT-PCR for stratification of UICC stage I and II patients into those likely to develop recurrent disease was not evident.

Ragnhammar P, Hafstrom L, Nygren P et al (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40–:282–308

Yarbro JW, Page DL, Fielding LP et al (1999) American Joint Committee on Cancer prognostic factors consensus conference. Cancer 86:2436–2446

Cohen AM, Tremiterra S, Candela F et al (1991) Prognosis of node-positive colon cancer. Cancer 67:1859–1861PubMed

Saha S, Bilchik A, Wiese D et al (2001) Ultrastaging of colorectal cancer by sentinel lymph node mapping technique-a multicenter trial. Ann Surg Oncol 8 [9 Suppl]:94S–98S

Merrie AE, Yun K, van Rij AM et al (1999) Detection and significance of minimal residual disease in colorectal cancer. Histol Histopathol 14:561–569PubMed

Yamamoto N, Kato Y, Yanagisawa A et al (1997) Predictive value of genetic diagnosis for cancer micrometastasis: histologic and experimental appraisal. Cancer 80:1393–1398

Hermanek P (1999) Disseminated tumor cells versus micrometastasis: definitions and problems. Anticancer Res 19:2771–2774PubMed

Tsavellas G, Patel H, Allen-Mersh TG (2001) Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg 88:1307–1320CrossRefPubMed

Pantel K, von Knebel Doeberitz M (2000) Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 12:95–101

10.

Ghossein RA, Bhattacharya S, Rosai J (1999) Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5:1950–1960PubMed

11.

Burchill SA, Selby PJ (2000) Molecular detection of low-level disease in patients with cancer. J Pathol 190:6–14CrossRefPubMed

12.

Sanchez-Cespedes M, Esteller M, Hibi K et al (1999) Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res 5:2450–2454

13.

Ghossein RA, Scher HI, Gerald WL et al (1995) Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 13:1195–1200PubMed

14.

Hoon DS, Wang Y, Dale PS et al (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109–2116PubMed

15.

Lindemann F, Schlimok G, Dirschedl, P et al (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340 685–689

16.

Calaluce R, Miedema BW, Yesus YW (1998) Micrometastasis in colorectal carcinoma: a review. J Surg Oncol 67:194–202CrossRefPubMed

17.

Ghossein RA, Carusone L, Bhattacharya S (1999) Review: polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate, and thyroid carcinomas. Diagn Mol Pathol 8:165–175CrossRefPubMed

18.

Moll R, Zimbelmann R, Goldschmidt MD et al (1993) The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 53:75–93PubMed

19.

Calnek D, Quaroni A (1993) Differential localization by in situ hybridization of distinct keratin mRNA species during intestinal epithelial cell development and differentiation. Differentiation 53:95–104PubMed

20.

Burchill SA, Bradbury MF, Pittman, K et al (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 71:278–281

21.

Moll R, Lowe A, Laufer J et al (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427–447PubMed

22.

Wildi S, Kleeff J, Maruyama H et al (1999) Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer. Clin Cancer Res 5:2840–2847PubMed

23.

Wharton RQ, Jonas SK, Glover C et al (1999) Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 5:4158–4163

24.

Bustin SA, Gyselman VG, Williams NS et al (1999) Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 79–:1813–1820

25.

Wyld DK, Selby P, Perren TJ et al (1998) Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 79:288–293CrossRef

26.

Funaki NO, Tanaka J, Ohshio G et al (1998) Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer 77:1327–1332

27.

Futamura M, Takagi Y, Koumura H et al (1998) Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 68:34–40CrossRefPubMed

28.

Rosenberg R, Hoos A, Mueller J et al (2002) Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 20:1049–1055CrossRefPubMed

29.

Yun K, Merrie AE, Gunn J et al (2000) Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations. J Pathol 191:21–26

30.

Miyake Y, Yamamoto H, Fujiwara Y et al (2001) Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping. Clin Cancer Res 7:1350–1357

31.

Litle VR, Warren RS, Moore D 2nd et al (1997) Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients. Cancer 79:1664–1670

32.

Weitz J, Kienle P, Magener A et al (1999) Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 5:1830–1836

33.

Merrie AE, Van Rij AM, Dennett ER et al (2003) Prognostic significance of occult metastases in colon cancer. Dis Colon Rectum 46:221–231PubMed

34.

Jung R, Petersen K, Kruger W et al (1999) Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 81:870–873

35.

Champelovier P, Mongelard F, Seigneurin D (1999) CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res 19:2073–2078PubMed

36.

Vlems FA, Diepstra JH, Cornelissen IM et al (2002) Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. Mol Pathol 55:156–163CrossRefPubMed

37.

Soong R, Beyser K, Basten O et al (2001) Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin Cancer Res 7:3423–3429

38.

Jeffers MD, O'Dowd GM, Mulcahy H et al (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172:183–187PubMed

39.

Greenson JK, Isenhart CE, Rice R et al (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563–569PubMed

40.

Lassmann S, Bauer M, Soong R et al (2002) Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity. J Pathol 198:198–206CrossRefPubMed

41.

Rosenberg R, Hoos A, Mueller J et al (2000) Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer 83:1323–1329CrossRefPubMed

Title: Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression
Authors: S. Lassmann
M. Bauer
R. Rosenberg
H. Nekarda
R. Soong
R. Rüger
H. Höfler
M. Werner
Publication date: 01-03-2004
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 2/2004
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-003-0530-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression

Abstract

Background and aims

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and aims

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2004

CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue

Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy

Effect of low molecular weight heparin on intra-abdominal metastasis in a laparoscopic experimental study

Gangrenous sigmoid volvulus: a clinical study of 76 patients

Comparison of early and 1-year follow-up results of conventional hemorrhoidectomy and hemorrhoid artery ligation: a randomized study

Pelvic sidewall involvement in recurrent rectal cancer